Special Issue "Enzymes from the Sea: Sources, Molecular Biology and Bioprocesses"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (28 February 2011)

Special Issue Editor

Guest Editor
Dr. Antonio Trincone
Istituto di Chimica Biomolecolare, Consiglio Nazionale delle Ricerche, Comprensorio Olivetti, Edificio 70, Via Campi Flegrei 34, I-80078 Pozzuoli, Napoli, Italy
Website: http://www.icb.cnr.it/people/antonio.trincone/
E-Mail: antonio.trincone@icb.cnr.it
Phone: +39 081 8675095
Fax: +39 081 8041770
Interests: biocatalysis; marine enzymes; marine glycosidases; marine biotechnology; oligosaccharides

Special Issue Information

Dear Colleagues,

Marine ecosystem is considered a rather unexplored source of natural bioactive substances with potential therapeutic activity and as consequence it should be also appreciated as a source of enzymes carrying new and surprising catalytic activities to be applied in biocatalysis. Notwithstanding commercial exploitations in marine biotechnology are not familiar as in the whole biotechnology field. The uniqueness of marine biocatalysts could characterize bioprocesses taking advantages by habitat-related properties such as salt tolerance, hyperthermostability, barophilicity, cold adaptivity, etc. But novelty brought out by marine enzymes is more pervasive, in fact new characteristics can be discovered at molecular level of catalysis specially concerning the stereochemical asset of products. The analysis of marine bio-processes from chemical and stereochemical viewpoints of catalysis could better reveal the potential of marine sources in biocatalysis. Substrate specificity and affinity play somehow leader roles. Both are evolved properties that are linked to the metabolic functions of the enzymes and to ecological asset related to the natural source. Consequently the range of available relevant catalysts is a key issue. Sources are represented by marine microorganism, plants and animals but great efforts are directed towards extremophiles or symbiotic microorganisms and towards molecular biology tools. The advent of PCR, the advances in recombinant expression systems, and the genomic research in general, allowed the access to new natural and modified enzymes useful for biotechnological purposes. As far as this genetic improvements are considered, attempts were made to enhance the stability and activity of such enzymes, or to increase their specificity for application as efficient catalysts. Setting up bioreactors for marine metabolite production is a key point in marine biotechnology. Special culture conditions and bioengineering including different immobilized cell technologies are of great interest in this field to increase production of natural products or analogs. In this special issue articles or reviews concerning bioprocesses will discuss more recent successes in chemical domain of catalysis with marine biocatalysts for promoting the in-depth knowledge in this field. Sources of enzymes, marine molecular biology tools and study of marine biocatalysis (including enzymatic characteristics such as yields, stereochemistry, special reaction conditions, isolation techniques, downstream aspects, structure of products obtained), will characterize this issue.

The potential of the marine habitat should be thoroughly known and possibly the way for access to an useful biocatalysts should avoid destructive large-scale collections of marine biomass for enzyme production. These two aspects are day by day becoming of interest and a future increase in articles dealing with the use of marine enzymes should be expected.

As the Guest Editor, I invite researchers from industry and academia, working with marine enzymes to describe recent advances in the field.

Dr. Antonio Trincone
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • enzymes
  • biocatalysts
  • marine ecology
  • marine biotechnology
  • biocatalysis
  • extremophiles
  • marine microorganisms

Published Papers (22 papers)

Open Access
Mar. Drugs 2009, 7(4), 672-688; doi:10.3390/md7040672
Received: 8 October 2009; in revised form: 30 October 2009 / Accepted: 2 November 2009 / Published: 25 November 2009
Show/Hide Abstract | Download PDF Full-text (229 KB) | Download XML Full-text

Open Access
Mar. Drugs 2009, 7(4), 803-815; doi:10.3390/md7040803
Received: 19 November 2009; in revised form: 10 December 2009 / Accepted: 14 December 2009 / Published: 15 December 2009
Show/Hide Abstract | Download PDF Full-text (281 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(1), 200-218; doi:10.3390/md8010200
Received: 6 January 2010; in revised form: 21 January 2010 / Accepted: 25 January 2010 / Published: 26 January 2010
Show/Hide Abstract | Download PDF Full-text (290 KB) | Download XML Full-text

Open Access
Mar. Drugs 2010, 8(2), 235-254; doi:10.3390/md8020235
Received: 23 December 2009; in revised form: 18 January 2010 / Accepted: 1 February 2010 / Published: 2 February 2010
Show/Hide Abstract | Download PDF Full-text (428 KB) | Download XML Full-text

Open Access
Mar. Drugs 2010, 8(2), 255-268; doi:10.3390/md8020255
Received: 14 December 2009; in revised form: 23 January 2010 / Accepted: 25 January 2010 / Published: 2 February 2010
Show/Hide Abstract | Download PDF Full-text (460 KB) | Download XML Full-text

Open Access
Mar. Drugs 2010, 8(3), 413-428; doi:10.3390/md8030413
Received: 28 December 2009; in revised form: 1 February 2010 / Accepted: 5 February 2010 / Published: 26 February 2010
Show/Hide Abstract | Download PDF Full-text (526 KB) | Download XML Full-text
abstract graphic

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(3), 519-541; doi:10.3390/md8030519
Received: 10 February 2010; in revised form: 21 February 2010 / Accepted: 22 February 2010 / Published: 5 March 2010
Show/Hide Abstract | Download PDF Full-text (934 KB) | Download XML Full-text
abstract graphic

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(3), 594-607; doi:10.3390/md8030594
Received: 8 January 2010; in revised form: 3 February 2010 / Accepted: 11 March 2010 / Published: 15 March 2010
Show/Hide Abstract | Download PDF Full-text (1245 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(3), 608-628; doi:10.3390/md8030608
Received: 20 January 2010; in revised form: 4 February 2010 / Accepted: 12 March 2010 / Published: 15 March 2010
Show/Hide Abstract | Download PDF Full-text (608 KB) | Download XML Full-text

Open Access
Mar. Drugs 2010, 8(4), 916-940; doi:10.3390/md8040916
Received: 20 February 2010; in revised form: 19 March 2010 / Accepted: 26 March 2010 / Published: 29 March 2010
Show/Hide Abstract | Download PDF Full-text (466 KB) | Download XML Full-text
abstract graphic

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(4), 1323-1372; doi:10.3390/md8041323
Received: 5 March 2010; in revised form: 31 March 2010 / Accepted: 12 April 2010 / Published: 19 April 2010
Show/Hide Abstract | Download PDF Full-text (373 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(6), 1920-1934; doi:10.3390/md8061920
Received: 10 May 2010; in revised form: 15 June 2010 / Accepted: 22 June 2010 / Published: 23 June 2010
Show/Hide Abstract | Download PDF Full-text (218 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2010, 8(11), 2781-2794; doi:10.3390/md8112781
Received: 20 September 2010; in revised form: 25 October 2010 / Accepted: 2 November 2010 / Published: 5 November 2010
Show/Hide Abstract | Download PDF Full-text (301 KB) | Download XML Full-text

Open Access
Mar. Drugs 2011, 9(1), 109-123; doi:10.3390/md9010109
Received: 2 January 2011; in revised form: 15 January 2011 / Accepted: 19 January 2011 / Published: 21 January 2011
Show/Hide Abstract | Download PDF Full-text (529 KB) | Download XML Full-text

Open Access
Mar. Drugs 2011, 9(2), 184-195; doi:10.3390/md9020184
Received: 17 December 2010; in revised form: 4 January 2011 / Accepted: 14 January 2011 / Published: 31 January 2011
Show/Hide Abstract | Download PDF Full-text (216 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2011, 9(4), 478-499; doi:10.3390/md9040478
Received: 9 February 2011; in revised form: 28 February 2011 / Accepted: 23 March 2011 / Published: 25 March 2011
Show/Hide Abstract | Download PDF Full-text (306 KB) | Download XML Full-text
abstract graphic

Open Access
Mar. Drugs 2011, 9(4), 586-602; doi:10.3390/md9040586
Received: 15 March 2011; in revised form: 1 April 2011 / Accepted: 7 April 2011 / Published: 11 April 2011
Show/Hide Abstract | Download PDF Full-text (486 KB) | Download XML Full-text
abstract graphic

Open Access Free, Open Access Review Article
Mar. Drugs 2011, 9(4), 645-665; doi:10.3390/md9040645
Received: 4 March 2011; in revised form: 1 April 2011 / Accepted: 13 April 2011 / Published: 21 April 2011
Show/Hide Abstract | Download PDF Full-text (435 KB) | Download XML Full-text

Open Access Free, Open Access Review Article
Mar. Drugs 2011, 9(5), 719-738; doi:10.3390/md9050719
Received: 20 March 2011; in revised form: 14 April 2011 / Accepted: 20 April 2011 / Published: 28 April 2011
Show/Hide Abstract | Download PDF Full-text (309 KB) | Download XML Full-text

Open Access
Mar. Drugs 2011, 9(5), 889-905; doi:10.3390/md9050889
Received: 20 April 2011; in revised form: 17 May 2011 / Accepted: 20 May 2011 / Published: 24 May 2011
Show/Hide Abstract | Download PDF Full-text (389 KB) | Download XML Full-text

Open Access
Mar. Drugs 2011, 9(5), 906-921; doi:10.3390/md9050906
Received: 17 February 2011; in revised form: 16 May 2011 / Accepted: 17 May 2011 / Published: 24 May 2011
Show/Hide Abstract | Download PDF Full-text (449 KB) | Download XML Full-text | Supplementary Files
abstract graphic

Open Access Free, Open Access Review Article
Mar. Drugs 2011, 9(7), 1220-1231; doi:10.3390/md9071220
Received: 27 May 2011; in revised form: 27 June 2011 / Accepted: 29 June 2011 / Published: 7 July 2011
Show/Hide Abstract | Download PDF Full-text (323 KB) | Download XML Full-text

Last update: 10 October 2012

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert